Podcast Episodes
Back to SearchWhen can stage II–III colon cancer be considered cured after treatment?
Episode 565
An analysis of 35,000 stage II–III colon cancer cases shows relapse risk peaks in year one and falls below 0.5% per six-month interval by year six, o…
1 year ago
ICML 2025: Novel Agents in CLL
Episode 564
Drs. Fahkri and Seshadri review abstracts from the 18th International Conference on Malignant Lymphoma in Lugano, Switzerland, exploring investigatio…
1 year ago
Could SGLT2 inhibitors help lower the risk of sudden cardiac death?
Episode 563
A new meta-analysis in HeartRhythm found that SGLT2 inhibitors reduced sudden cardiac death risk by about 18% across patients with type 2 diabetes, h…
1 year ago
ICML 2025: Regimens for Patients With High-Risk CLL
Episode 562
Drs. Seshadri and Fahkri review abstracts exploring treatments for patients with high-risk CLL, including SEQUOIA Arm C and CLL16 studies.
1 year ago
ICML 2025: Fixed-Duration and MRD-Guided Regimens in CLL
Episode 561
Drs. Fahkri and Seshadri discuss recent studies on novel fixed-duration combinations and MRD-guided regimens for CLL. The Sequoia RMD study showed hi…
1 year ago
CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension
Episode 560
Drs. Hindiyeh and Hutchinson review new FDA-issued safety warnings for Raynaud's phenomenon and hypertension in CGRP-based migraine treatment. They e…
1 year ago
Should children under 4 still get the MMRV vaccine? The American Academy of Pediatrics says yes
Episode 559
The CDC’s advisory panel voted to recommend separate MMR and varicella shots for children under four, citing a slight seizure risk with the combined …
1 year ago
Breaking the Migraine Cycle: Understanding Medication Overuse Headache
Episode 558
Drs. Hutchinson and Hindiyeh discuss medication overuse headache, including some clinical features, diagnostic criteria, and management strategies.
1 year ago
Future Directions in Small Cell Lung Cancer Treatment
Episode 557
Drs. Liu and Scott discuss the future of small cell lung cancer treatment, reviewing emerging strategies including immunotherapy, antibody–drug conju…
1 year ago
Small Cell Lung Cancer: Second-line Options Following Maintenance
Episode 556
Drs. Liu and Scott review second-line treatments of small cell lung cancer following first-line maintenance treatment, including platinum rechallenge…
1 year ago